Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

A$2.7m Equity Placement to Fund Laverton Drilling Campaign

by admin June 30, 2025
June 30, 2025
A$2.7m Equity Placement to Fund Laverton Drilling Campaign

Sarama Resources (SRR:AU) has announced A$2.7m Equity Placement to Fund Laverton Drilling Campaign

Download the PDF here.

This post appeared first on investingnews.com

previous post
Merger Discussions Between Brightstar and Aurumin
next post
A$4.5M Placement to Underpin Resource Growth Strategy

Related Posts

Finlay Minerals Receives TSX Venture Exchange Approval for...

May 3, 2025

Top 5 Silver News Stories of 2025

December 30, 2025

Inca to Raise $1.1M

April 1, 2025

Tech 5: DeepSeek Disrupts AI Landscape, Tech Stocks...

February 2, 2025

Syntholene Selects Papadakis Engineering as Integration Partner for...

March 12, 2026

Heliostar Presents Third Quarter 2025 Financial Results

November 21, 2025

6 Biggest Crypto Mining Stocks

February 7, 2025

Copper Quest Exploration

February 25, 2026

Metals Focus: PGMs Deficits Deepen as Supply Tightens...

May 21, 2025

Valeura Energy Inc. Announces Record 2P Reserves, Higher...

February 10, 2026

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved